These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 26352862

  • 21. A human scFv antibody against TRAIL receptor 2 induces autophagic cell death in both TRAIL-sensitive and TRAIL-resistant cancer cells.
    Park KJ, Lee SH, Kim TI, Lee HW, Lee CH, Kim EH, Jang JY, Choi KS, Kwon MH, Kim YS.
    Cancer Res; 2007 Aug 01; 67(15):7327-34. PubMed ID: 17671202
    [Abstract] [Full Text] [Related]

  • 22. Autophagy facilitates the development of resistance to the tumor necrosis factor superfamily member TRAIL in breast cancer.
    Lv S, Wang X, Zhang N, Sun M, Qi W, Li Y, Yang Q.
    Int J Oncol; 2015 Mar 01; 46(3):1286-94. PubMed ID: 25572822
    [Abstract] [Full Text] [Related]

  • 23. Chloroquine augments TRAIL-induced apoptosis and induces G2/M phase arrest in human pancreatic cancer cells.
    Monma H, Iida Y, Moritani T, Okimoto T, Tanino R, Tajima Y, Harada M.
    PLoS One; 2018 Mar 01; 13(3):e0193990. PubMed ID: 29513749
    [Abstract] [Full Text] [Related]

  • 24. Genistein potentiates the antitumor effect of 5-Fluorouracil by inducing apoptosis and autophagy in human pancreatic cancer cells.
    Suzuki R, Kang Y, Li X, Roife D, Zhang R, Fleming JB.
    Anticancer Res; 2014 Sep 01; 34(9):4685-92. PubMed ID: 25202045
    [Abstract] [Full Text] [Related]

  • 25. The dietary isoflavone biochanin-A sensitizes prostate cancer cells to TRAIL-induced apoptosis.
    Szliszka E, Czuba ZP, Mertas A, Paradysz A, Krol W.
    Urol Oncol; 2013 Apr 01; 31(3):331-42. PubMed ID: 21803611
    [Abstract] [Full Text] [Related]

  • 26. Soy isoflavones augment the effect of TRAIL-mediated apoptotic death in prostate cancer cells.
    Szliszka E, Krol W.
    Oncol Rep; 2011 Sep 01; 26(3):533-41. PubMed ID: 21637922
    [Abstract] [Full Text] [Related]

  • 27. 2-Deoxy-D-glucose enhances TRAIL-induced apoptosis in human gastric cancer cells through downregulating JNK-mediated cytoprotective autophagy.
    Xu Y, Wang Q, Zhang L, Zheng M.
    Cancer Chemother Pharmacol; 2018 Mar 01; 81(3):555-564. PubMed ID: 29383484
    [Abstract] [Full Text] [Related]

  • 28. Targeting KPNB1 overcomes TRAIL resistance by regulating DR5, Mcl-1 and FLIP in glioblastoma cells.
    Zhu ZC, Liu JW, Yang C, Li MJ, Wu RJ, Xiong ZQ.
    Cell Death Dis; 2019 Feb 11; 10(2):118. PubMed ID: 30742128
    [Abstract] [Full Text] [Related]

  • 29. c-Jun N-terminal kinase activation by nitrobenzoxadiazoles leads to late-stage autophagy inhibition.
    Palumbo C, De Luca A, Rosato N, Forgione M, Rotili D, Caccuri AM.
    J Transl Med; 2016 Feb 04; 14():37. PubMed ID: 26847645
    [Abstract] [Full Text] [Related]

  • 30. Antihypertensive drug-candesartan attenuates TRAIL resistance in human lung cancer via AMPK-mediated inhibition of autophagy flux.
    Rasheduzzaman M, Park SY.
    Exp Cell Res; 2018 Jul 01; 368(1):126-135. PubMed ID: 29694835
    [Abstract] [Full Text] [Related]

  • 31. Autophagy induction enhances tetrandrine-induced apoptosis via the AMPK/mTOR pathway in human bladder cancer cells.
    Kou B, Liu W, Xu X, Yang Y, Yi Q, Guo F, Li J, Zhou J, Kou Q.
    Oncol Rep; 2017 Nov 01; 38(5):3137-3143. PubMed ID: 29048631
    [Abstract] [Full Text] [Related]

  • 32. Autophagy-Mediated Degradation of IAPs and c-FLIP(L) Potentiates Apoptosis Induced by Combination of TRAIL and Chal-24.
    Xu J, Xu X, Shi S, Wang Q, Saxton B, He W, Gou X, Jang JH, Nyunoya T, Wang X, Xing C, Zhang L, Lin Y.
    J Cell Biochem; 2016 May 01; 117(5):1136-44. PubMed ID: 26448608
    [Abstract] [Full Text] [Related]

  • 33. Autophagic flux disruption contributes to Ganoderma lucidum polysaccharide-induced apoptosis in human colorectal cancer cells via MAPK/ERK activation.
    Pan H, Wang Y, Na K, Wang Y, Wang L, Li Z, Guo C, Guo D, Wang X.
    Cell Death Dis; 2019 Jun 11; 10(6):456. PubMed ID: 31186406
    [Abstract] [Full Text] [Related]

  • 34. The combination of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL/Apo2L) and Genistein is effective in inhibiting pancreatic cancer growth.
    Nozawa F, Itami A, Saruc M, Kim M, Standop J, Picha KS, Cowan KH, Pour PM.
    Pancreas; 2004 Jul 11; 29(1):45-52. PubMed ID: 15211111
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Genistein targets the cancerous inhibitor of PP2A to induce growth inhibition and apoptosis in breast cancer cells.
    Zhao Q, Zhao M, Parris AB, Xing Y, Yang X.
    Int J Oncol; 2016 Sep 11; 49(3):1203-10. PubMed ID: 27574003
    [Abstract] [Full Text] [Related]

  • 37. Hypoxia‑mediated activation of autophagic flux inhibits apoptosis of keratinocytes via blocking tumor necrosis factor‑related apoptosis‑inducing ligand.
    Kim SW, Park SY.
    Mol Med Rep; 2016 Jan 11; 13(1):805-10. PubMed ID: 26648440
    [Abstract] [Full Text] [Related]

  • 38. Niacin alleviates TRAIL-mediated colon cancer cell death via autophagy flux activation.
    Kim SW, Lee JH, Moon JH, Nazim UM, Lee YJ, Seol JW, Hur J, Eo SK, Lee JH, Park SY.
    Oncotarget; 2016 Jan 26; 7(4):4356-68. PubMed ID: 26517672
    [Abstract] [Full Text] [Related]

  • 39. Tanshinone IIA induces TRAIL sensitization of human lung cancer cells through selective ER stress induction.
    Kim EO, Kang SE, Im CR, Lee JH, Ahn KS, Yang WM, Um JY, Lee SG, Yun M.
    Int J Oncol; 2016 May 26; 48(5):2205-12. PubMed ID: 26983803
    [Abstract] [Full Text] [Related]

  • 40. Triptolide enhances TRAIL sensitivity of pancreatic cancer cells by activating autophagy via downregulation of PUM1.
    Dai H, Jiang Y, Luo Y, Bie P, Chen Z.
    Phytomedicine; 2019 Sep 26; 62():152953. PubMed ID: 31128486
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.